{"downloaded": true, "htmlmade": false, "full": {"id": "33828995", "source": "MED", "pmid": "33828995", "pmcid": "PMC8019914", "fullTextIdList": {"fullTextId": "PMC8019914"}, "doi": "10.3389/fonc.2021.664883", "title": "Molecular Characteristics of Genes and the Immune Microenvironment of a Rare Chest Malignant Tumor (Pulmonary Clear Cell Sarcoma): A Case Report.", "authorString": "Xu X, Wang D, Wu W, Lu H.", "authorList": {"author": [{"fullName": "Xu X", "firstName": "Xiaoling", "lastName": "Xu", "initials": "X", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Thoracic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China."}, {"affiliation": "Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China."}]}}, {"fullName": "Wang D", "firstName": "Ding", "lastName": "Wang", "initials": "D", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Thoracic Surgery, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China."}}}, {"fullName": "Wu W", "firstName": "Wei", "lastName": "Wu", "initials": "W", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Department of Pathology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China."}}}, {"fullName": "Lu H", "firstName": "Hongyang", "lastName": "Lu", "initials": "H", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Department of Thoracic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China."}, {"affiliation": "Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China."}, {"affiliation": "Zhejiang Key Laboratory of Diagnosis & Treatment Technology on Thoracic Oncology (Lung and Esophagus), Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China."}]}}]}, "dataLinksTagsList": {"dataLinkstag": "altmetrics"}, "journalInfo": {"volume": "11", "journalIssueId": "3115901", "dateOfPublication": "2021", "monthOfPublication": "0", "yearOfPublication": "2021", "printPublicationDate": "2021-01-01", "journal": {"title": "Frontiers in oncology", "ISOAbbreviation": "Front Oncol", "medlineAbbreviation": "Front Oncol", "NLMid": "101568867", "ISSN": "2234-943X", "ESSN": "2234-943X"}}, "pubYear": "2021", "pageInfo": "664883", "abstractText": "Pulmonary clear cell sarcoma is a rare malignant tumor that has rarely been reported and is challenging to diagnose, especially when differentiating from malignant melanoma. Currently, EWSR1-ATF1 is the key marker for distinguishing clear cell sarcoma from melanoma, but IHC has diagnostic limitations. We report a patient diagnosed with pulmonary clear cell sarcoma, in which an NGS was used to help with the pathological diagnosis. The exposure to the immune microenvironment in pulmonary clear cell sarcoma suggests that TIGIT-related drugs may be a new and effective treatment for this rare disease. Immune microenvironment-related markers, including PD-L1, CD8, TIM3, LAG3, and CD163, were negatively expressed in pulmonary clear cell sarcoma.", "affiliation": "Department of Thoracic Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.", "publicationStatus": "epublish", "language": "eng", "pubModel": "Electronic-eCollection", "pubTypeList": {"pubType": ["Case Reports", "case-report"]}, "keywordList": {"keyword": ["Lung", "PD-L1", "Next-generation Sequencing", "Clear Cell Sarcoma", "Tigit", "Ews-Atf1"]}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.3389/fonc.2021.664883"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC8019914"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC8019914?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "N", "citedByCount": "0", "hasData": "N", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCreation": "2021-04-08", "firstIndexDate": "2021-04-09", "fullTextReceivedDate": "2021-04-07", "dateOfRevision": "2021-04-09", "electronicPublicationDate": "2021-03-22", "firstPublicationDate": "2021-03-22"}, "htmllinks": "https://europepmc.org/articles/PMC8019914", "abstract": "Pulmonary clear cell sarcoma is a rare malignant tumor that has rarely been reported and is challenging to diagnose, especially when differentiating from malignant melanoma. Currently, EWSR1-ATF1 is the key marker for distinguishing clear cell sarcoma from melanoma, but IHC has diagnostic limitations. We report a patient diagnosed with pulmonary clear cell sarcoma, in which an NGS was used to help with the pathological diagnosis. The exposure to the immune microenvironment in pulmonary clear cell sarcoma suggests that TIGIT-related drugs may be a new and effective treatment for this rare disease. Immune microenvironment-related markers, including PD-L1, CD8, TIM3, LAG3, and CD163, were negatively expressed in pulmonary clear cell sarcoma.", "Keywords": ["Lung", "PD-L1", "Next-generation Sequencing", "Clear Cell Sarcoma", "Tigit", "Ews-Atf1"], "pdflinks": "https://europepmc.org/articles/PMC8019914?pdf=render", "journaltitle": "Frontiers in oncology", "authorinfo": ["Xu X", "Wang D", "Wu W", "Lu H"], "title": "Molecular Characteristics of Genes and the Immune Microenvironment of a Rare Chest Malignant Tumor (Pulmonary Clear Cell Sarcoma): A Case Report."}